Hyperpigmentation
Melasma
Melasma is a chronic, acquired disorder that operates across multiple biological layers simultaneously — epidermal, dermal, and vascular.
It is driven by a self-sustaining network of triggers that continues to stimulate melanocytes even in the absence of new UV exposure.
This is what makes it one of the most challenging pigmentation conditions to manage, and why single-target approaches so often fall short.
What it is
Melasma is characterized by irregular brown to gray-brown patches, predominantly on sun-exposed areas of the face. It affects primarily Fitzpatrick phototypes III to VI, with a strong genetic predisposition, and is significantly more prevalent in women - particularly during hormonal shifts such as pregnancy or contraceptive use.
Importantly, it is not simply a cosmetic concern. Its psychosocial impact is well-documented, and its chronic, relapsing nature requires long-term management rather than a one-time treatment.
What sets melasma apart is the breadth of its biological drivers - not limited to excess melanin production, but a self-reinforcing microenvironment spanning three distinct skin compartments.
At the epidermal level, keratinocytes under chronic stress continuously activate melanocytes independently of UV exposure. At the dermal level, senescent fibroblasts release pro-pigment growth factors while MMP-mediated collagen degradation allows melanocytes to migrate deeper.At the vascular level, increased vessel density elevates local temperature and ROS signaling, while vsoactive mediators and nitric oxide actively sustain melanocyte activity.
Melasma management therefore requires acting on these pathways simultaneously to ensure long-term treatment efficacy.
Mela Bright [C+] : Formulated to address melasma’s complexity
Mela Bright [C+] was developed specifically to address melasma’s multi-pathway nature. Built around stabilized Cysteamine as its anchor active - one of the most powerful depigmenting molecules in cosmeceutical science - and combined with pure L-Ascorbic Acid and Ginkgo Biloba, it acts simultaneously on melanin production, oxidative stress, inflammation, and vascular signaling.
The result is a formula that targets the condition at every level where it operates.
Discover MELA BRIGHT [C+]
Strategies in melasma management
Managing melasma effectively requires thinking in three simultaneous directions:
Limiting triggers is non-negotiable and foundational. Broad-spectrum UVA/UVB protection must be applied daily and consistently. Heat, hormonal factors, and irritating skincare routines are equally important to address.
Reducing pigment production is driven by a pigment correcting topical formula. Prescription approaches including short cycles of hydroquinone and/or systemic options remain relevant in specific clinical contexts.
Procedural interventions such as chemical peels, low-fluence or pico lasers, and microneedling can significantly accelerate results, but carry a risk of post-inflammatory hyperpigmentation if the skin is not properly prepared and supported. A well-structured cosmeceutical protocol before and after any procedure is essential to protect the outcome.